Cooper Companies (COO)
$
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
About
Business overview of The Cooper Companies (COO)
CooperCompanies is one of the largest eyecare companies in the us. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the us contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the us, and controls 17% of the us IUD market.
Key Insights
Critical company metrics and information
Share Price
$98.50Market Cap
$19.62 BillionTotal Outstanding Shares
199.16 Million SharesTotal Employees
15,000Dividend
$0.03 Per Share BiannuallyIPO Date
December 6, 1983SIC Description
Ophthalmic GoodsHomepage
https://www.coopercos.com
Historical Stock Splits
If you bought 1 share of COO before February 20, 2024, you'd have 4 shares today.
Execution Date | Split Amount |
---|---|
February 20, 2024 | 4-for-1 |
Cash Flow Statement
November 1, 2023 to October 31, 2024
Metric | Value |
---|---|
Net Cash Flow | $-13.20 Million |
Net Cash Flow From Operating Activities, Continuing | $709.30 Million |
Exchange Gains/Losses | $2.90 Million |
Net Cash Flow From Operating Activities | $709.30 Million |
Net Cash Flow From Financing Activities | $39.20 Million |
Net Cash Flow, Continuing | $-16.10 Million |
Net Cash Flow From Investing Activities, Continuing | $-764.60 Million |
Net Cash Flow From Investing Activities | $-764.60 Million |
Net Cash Flow From Financing Activities, Continuing | $39.20 Million |
Income Statement
November 1, 2023 to October 31, 2024
Metric | Value |
---|---|
Selling, General, and Administrative Expenses | $1.53 Billion |
Income Tax Expense/Benefit, Deferred | $118.90 Million |
Nonoperating Income/Loss | $-9.10 Million |
Operating Expenses | $1.89 Billion |
Basic Earnings Per Share | $1.97 |
Net Income/Loss Attributable To Parent | $392.30 Million |
Gross Profit | $2.60 Billion |
Basic Average Shares | $198.90 Million |
Diluted Earnings Per Share | $1.96 |
Income Tax Expense/Benefit | $190.00 Million |
Research and Development | $155.10 Million |
Operating Income/Loss | $705.70 Million |
Income Tax Expense/Benefit, Current | $71.10 Million |
Diluted Average Shares | $200.40 Million |
Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
Benefits Costs and Expenses | $3.31 Billion |
Preferred Stock Dividends And Other Adjustments | $0.00 |
Net Income/Loss | $392.30 Million |
Other Operating Expenses | $201.20 Million |
Revenues | $3.90 Billion |
Costs And Expenses | $3.31 Billion |
Income/Loss From Continuing Operations After Tax | $392.30 Million |
Income/Loss From Continuing Operations Before Tax | $582.30 Million |
Net Income/Loss Available To Common Stockholders, Basic | $392.30 Million |
Cost Of Revenue | $1.30 Billion |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
Balance Sheet
November 1, 2023 to October 31, 2024
Metric | Value |
---|---|
Wages | $174.80 Million |
Equity | $8.08 Billion |
Fixed Assets | $1.86 Billion |
Current Liabilities | $1.02 Billion |
Current Assets | $1.95 Billion |
Other Current Liabilities | $587.50 Million |
Intangible Assets | $1.79 Billion |
Liabilities And Equity | $12.32 Billion |
Other Non-current Assets | $6.71 Billion |
Assets | $12.32 Billion |
Accounts Payable | $260.50 Million |
Liabilities | $4.23 Billion |
Equity Attributable To Noncontrolling Interest | $200,000.00 |
Noncurrent Assets | $10.36 Billion |
Inventory | $802.70 Million |
Other Current Assets | $1.15 Billion |
Noncurrent Liabilities | $3.21 Billion |
Equity Attributable To Parent | $8.08 Billion |
Historical Dividends
Current dividend: $0.03 Per Share Biannually
Announcement Date | Payment Date | Record Date | Amount | Frequency |
---|---|---|---|---|
Jul 12, 2023 | Aug 11, 2023 | Jul 27, 2023 | $0.03 | Biannually |
Dec 14, 2022 | Feb 10, 2023 | Jan 23, 2023 | $0.03 | Biannually |
Jul 13, 2022 | Aug 11, 2022 | Jul 27, 2022 | $0.03 | Biannually |
Dec 8, 2021 | Feb 9, 2022 | Jan 21, 2022 | $0.03 | Biannually |
Jul 14, 2021 | Aug 11, 2021 | Jul 27, 2021 | $0.03 | Biannually |
Jan 7, 2021 | Feb 9, 2021 | Jan 22, 2021 | $0.03 | Biannually |
Jul 9, 2020 | Aug 7, 2020 | Jul 23, 2020 | $0.03 | Biannually |
Jan 7, 2020 | Feb 10, 2020 | Jan 23, 2020 | $0.03 | Biannually |
Jul 10, 2019 | Aug 7, 2019 | Jul 23, 2019 | $0.03 | Biannually |
Jan 7, 2019 | Feb 8, 2019 | Jan 22, 2019 | $0.03 | Biannually |
Jul 12, 2018 | Aug 7, 2018 | Jul 23, 2018 | $0.03 | Biannually |
Jan 4, 2018 | Feb 9, 2018 | Jan 23, 2018 | $0.03 | Biannually |
Jul 6, 2017 | Aug 7, 2017 | Jul 21, 2017 | $0.03 | Biannually |
Jan 5, 2017 | Feb 9, 2017 | Jan 23, 2017 | $0.03 | Biannually |
Jul 7, 2016 | Aug 5, 2016 | Jul 22, 2016 | $0.03 | Biannually |
Jan 7, 2016 | Feb 9, 2016 | Jan 22, 2016 | $0.03 | Biannually |
Jul 9, 2015 | Aug 6, 2015 | Jul 24, 2015 | $0.03 | Biannually |
Jan 8, 2015 | Feb 9, 2015 | Jan 23, 2015 | $0.03 | Biannually |
Jul 10, 2014 | Aug 6, 2014 | Jul 24, 2014 | $0.03 | Biannually |
Jan 8, 2014 | Feb 7, 2014 | Jan 24, 2014 | $0.03 | Biannually |
Jul 11, 2013 | Aug 6, 2013 | Jul 24, 2013 | $0.03 | Biannually |
Jan 8, 2013 | Feb 7, 2013 | Jan 25, 2013 | $0.03 | Biannually |
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
â“’ 2024 Financhle. All Rights Reserved.